Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(IDCW)

Scheme Returns

0.67%

Category Returns

4.89%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(IDCW) 1.08 4.57 0.67 -0.33 17.80 18.63 15.80 22.20 20.37
Equity - Sectoral Fund - Pharma & Health Care 1.34 5.86 4.89 4.23 13.88 21.77 22.85 29.51 17.28

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    20,084.63

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    114.8016

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032

  • Phone

    (040) 23312454 23320751 23320752

  • Fax

    (040) 23311968

  • Email

    customercare@karvy.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 99.46
Others : 0.54

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 108528.89 13.43
Divi's Laboratories Limited 75012.01 9.28
Lupin Limited 58772.55 7.27
Cipla Limited 46150.4 5.71
Apollo Hospitals Enterprise Limited 42925.57 5.31
Dr. Reddy's Laboratories Limited 41902.55 5.19
GlaxoSmithKline Pharmaceuticals Limited 29146.87 3.61
Vijaya Diagnostic Centre Limited 28519.51 3.53
Abbott India Limited 27935.12 3.46
MedPlus Health Services Limited 27567.31 3.41
Ajanta Pharma Limited 25163.04 3.11
Gland Pharma Limited 24353.4 3.01
Narayana Hrudayalaya Limited 24131.51 2.99
Aurobindo Pharma Limited 19759.02 2.45
Zydus Lifesciences Limited 17733.6 2.19
Dr. Lal Path Labs Limited 17577.47 2.18
Torrent Pharmaceuticals Limited 16248.34 2.01
JB Chemicals & Pharmaceuticals Limited 16226.3 2.01
Alkem Laboratories Limited 15800.99 1.96
Mankind Pharma Limited 15737.5 1.95
Sanofi India Limited 13183.99 1.63
Pfizer Limited 12744.28 1.58
Thyrocare Technologies Limited 12001.52 1.49
IPCA Laboratories Limited 11796.1 1.46
Sai Life Sciences Limited 10883.37 1.35
Sanofi Consumer Healthcare India Limited 10312.79 1.28
Suraksha Diagnostic Limited 8215.65 1.02
Syngene International Limited 8168.26 1.01
Biocon Limited 7805.19 0.97
Fortis Healthcare Limited 7709.01 0.95
Triparty Repo 5648.12 0.7
AstraZeneca Pharma India Limited 5515.61 0.68
Indoco Remedies Limited 4273.35 0.53
Orchid Pharma Limited 3824.05 0.47
Emcure Pharmaceuticals Limited 3236.94 0.4
Krishna Institute Of Medical Sciences Limited 2953.58 0.37
Concord Biotech Limited 1877.87 0.23
Cash Margin - CCIL 3.4 0
Net Current Assets -1248.04 -0.15

Sectors - Holding Percentage

Sector hold percentage
Healthcare 98.44%
Business Services 1.01%
Miscellaneous 0.7%

Divident Details

Scheme Name Date Dividend (%)
Nippon India Pharma Fund 05-03-2018 6
Nippon India Pharma Fund 05-03-2019 5
Nippon India Pharma Fund 02-03-2020 4.5
Nippon India Pharma Fund 01-03-2021 6
Nippon India Pharma Fund 28-02-2022 3.5
Nippon India Pharma Fund 26-02-2024 10
Nippon India Pharma Fund 21-02-2025 10

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
UTI Healthcare Fund - Regular Plan - IDCW 682.85 -0.6 -3.03 -5.57 22.76 19.11
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 1637.91 3.97 -0.68 -1.44 20.37 22.5
NIPPON INDIA PHARMA FUND - IDCW Option 200.85 0.67 -0.33 -5.06 17.8 18.63

Other Funds From - Nippon India Pharma Fund(IDCW)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 61973.76 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 61646.36 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 61027.03 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 60999.55 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 60372.55 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 57009.7 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 56468.75 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 55490.73 3.06 -4.3 -12.69 6.74 21.04
Nippon India Small Cap Fund - Growth Plan - Growth Option 51566.11 3.06 -4.3 -12.69 6.74 21.04